|
1
|
Kneihsl M, Enzinger C, Wünsch G, Khalil M,
Culea V, Urbanic-Purkart T, Payer F, Niederkorn K, Fazekas F and
Gattringer T: Poor short-term outcome in patients with ischaemic
stroke and active cancer. J Neurol. 263:150–156. 2016. View Article : Google Scholar
|
|
2
|
Newton HB: Neurologic complications of
systemic cancer. Am Fam Physician. 59:878–886. 1999.PubMed/NCBI
|
|
3
|
Arboix A: Cerebrovascular disease in the
cancer patient. Rev Neurol. 31:1250–1252. 2000.In Spanish.
|
|
4
|
Grisold W, Oberndorfer S and Struhal W:
Stroke and cancer: A review. Acta Neurol Scand. 119:1–16. 2009.
View Article : Google Scholar
|
|
5
|
Taccone FS, Jeangette SM and Blecic SA:
First-ever stroke as initial presentation of systemic cancer. J
Stroke Cerebrovasc Dis. 17:169–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Selvik HA, Thomassen L, Logallo N and Næss
H: Prior cancer in patients with ischemic stroke: The Bergen
NORSTROKE study. J Stroke Cerebrovasc Dis. 23:919–925. 2014.
View Article : Google Scholar
|
|
7
|
Selvik HA, Thomassen L, Bjerkreim AT and
Næss H: Cancer-Associated Stroke: The Bergen NORSTROKE Study.
Cerebrovasc Dis Extra. 5:107–113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanossian N, Djabiras C, Mack WJ and
Ovbiagele B: Trends in cancer diagnoses among inpatients
hospitalized with stroke. J Stroke Cerebrovasc Dis. 22:1146–1150.
2013. View Article : Google Scholar
|
|
9
|
Cestari DM, Weine DM, Panageas KS, Segal
AZ and DeAngelis LM: Stroke in patients with cancer: Incidence and
etiology. Neurology. 62:2025–2030. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang YY, Chan DK, Cordato D, Shen Q and
Sheng AZ: Stroke risk factor, pattern and outcome in patients with
cancer. Acta Neurol Scand. 114:378–383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Graus F, Rogers LR and Posner JB:
Cerebrovascular complications in patients with cancer. Medicine
(Baltimore). 64:16–35. 1985. View Article : Google Scholar
|
|
12
|
De Bruin ML, Dorresteijn LD, van't Veer
MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM and
van Leeuwen FE: Increased risk of stroke and transient ischemic
attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst.
101:928–937. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lindvig K, Møller H, Mosbech J and Jensen
OM: The pattern of cancer in a large cohort of stroke patients. Int
J Epidemiol. 19:498–504. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bowers DC, McNeil DE, Liu Y, Yasui Y,
Stovall M, Gurney JG, Hudson MM, Donaldson SS, Packer RJ, Mitby PA,
et al: Stroke as a late treatment effect of Hodgkin's Disease: A
report from the Childhood Cancer Survivor Study. J Clin Oncol.
23:6508–6515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stefan O, Vera N, Otto B, Heinz L and
Wolfgang G: Stroke in cancer patients: A risk factor analysis. J
Neurooncol. 94:221–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zöller B, Ji J, Sundquist J and Sundquist
K: Risk of haemorrhagic and ischaemic stroke in patients with
cancer: A nationwide follow-up study from Sweden. Eur J Cancer.
48:1875–1883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee EJ, Nah HW, Kwon JY, Kang DW, Kwon SU
and Kim JS: Ischemic stroke in patients with cancer: Is it
different from usual strokes? Int J Stroke. 9:406–412. 2014.
View Article : Google Scholar
|
|
18
|
Sheng B, Fong MK, Chu YP, Cheong AP, Teng
SK, Chu JP, Yip WM and Chow DH: Stroke and cancer: Misfortunes
never come singularly. Int J Stroke. 8:E302013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carrilho Romeiro A, Valadas A and Marques
J: Acute ischemic stroke on cancer patients, a distinct etiology? A
case-control study. Acta Med Port. 28:613–618. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katz JM and Segal AZ: Incidence and
etiology of cerebro-vascular disease in patients with malignancy.
Curr Atheroscler Rep. 7:280–288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Donato J, Campigotto F, Uhlmann EJ,
Coletti E, Neuberg D, Weber GM and Zwicker JI: Intracranial
hemorrhage in patients with brain metastases treated with
therapeutic enoxaparin: A matched cohort study. Blood. 126:494–499.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rogers LR: Cerebrovascular complications
in cancer patients. Neurol Clin. 9:889–899. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rogers LR: Cerebrovascular complications
in patients with cancer. Semin Neurol. 24:453–460. 2004. View Article : Google Scholar
|
|
24
|
Navi BB, Reiner AS, Kamel H, Iadecola C,
Elkind MS, Panageas KS and DeAngelis LM: Association between
incident cancer and subsequent stroke. Ann Neurol. 77:291–300.
2015. View Article : Google Scholar :
|
|
25
|
Aarnio K, Joensuu H, Haapaniemi E, Melkas
S, Kaste M, Tatlisumak T and Putaala J: Cancer in young adults with
ischemic stroke. Stroke. 46:1601–1606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dearborn JL, Urrutia VC and Zeiler SR:
Stroke and cancer: A complicated relationship. J Neurol Transl
Neurosci. 2:10392014.
|
|
27
|
Karlińska AG, Gromadzka G, Karliński MA
and Członkowska A: The activity of malignancy may determine stroke
pattern in cancer patients. J Stroke Cerebrovasc Dis. 24:778–783.
2015. View Article : Google Scholar
|
|
28
|
Cocho D, Gendre J, Boltes A, Espinosa J,
Ricciardi AC, Pons J, Jimenez M and Otermin P: Predictors of occult
cancer in acute ischemic stroke patients. J Stroke Cerebrovasc Dis.
24:1324–1328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chamberlain MC: Leptomeningeal metastasis.
Semin Neurol. 30:236–244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Herman C, Kupsky WJ, Rogers L, Duman R and
Moore P: Leptomeningeal dissemination of malignant glioma
simulating cerebral vasculitis. Case report with angiographic and
pathological studies. Stroke. 26:2366–2370. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Raizer JJ and DeAngelis LM: Cerebral sinus
thrombosis diagnosed by MRI and MR venography in cancer patients.
Neurology. 54:1222–1226. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Klein P, Haley EC, Wooten GF and
VandenBerg SR: Focal cerebral infarctions associated with
perivascular tumor infiltrates in carcinomatous leptomeningeal
metastases. Arch Neurol. 46:1149–1152. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ichord R: Cerebral sinovenous thrombosis.
Front Pediatr. 5:1632017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ranta S, Tuckuviene R, Mäkipernaa A,
Albertsen BK, Frisk T, Tedgård U, Jónsson ÓG, Pruunsild K,
Gretenkort Andersson N, Winther Gunnes M, et al: Cerebral sinus
venous thromboses in children with acute lymphoblastic leukaemia -
a multicentre study from the Nordic Society of Paediatric
Haematology and Oncology. Br J Haematol. 168:547–552. 2015.
View Article : Google Scholar
|
|
35
|
Rogers LR: Cerebrovascular complications
in patients with cancer. Semin Neurol. 30:311–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Santoro N, Giordano P, Del Vecchio GC,
Guido G, Rizzari C, Varotto S, Masera G and De Mattia D: Ischemic
stroke in children treated for acute lymphoblastic leukemia: A
retrospective study. J Pediatr Hematol Oncol. 27:153–157. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anghel G, Petrinato G, Severino A, Remotti
D, Insabato L, De Renzo A, Rotoli B and Majolino I: Intravascular
B-cell lymphoma: Report of two cases with different clinical
presentation but rapid central nervous system involvement. Leuk
Lymphoma. 44:1353–1359. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fonkem E, Lok E, Robison D, Gautam S and
Wong ET: The natural history of intravascular lymphomatosis. Cancer
Med. 3:1010–1024. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lefkovitz NW, Roessmann U and Kori SH:
Major cerebral infarction from tumor embolus. Stroke. 17:555–557.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zheng Z, Guo G, Xu L, Lei L, Wei X and Pan
Y: Left atrial myxoma with versus without cerebral embolism: Length
of symptoms, morphologic characteristics, and outcomes. Tex Heart
Inst J. 41:592–595. 2014. View Article : Google Scholar
|
|
41
|
Murata J, Sawamura Y, Takahashi A, Abe H
and Saitoh H: Intracerebral hemorrhage caused by a neoplastic
aneurysm from small-cell lung carcinoma: Case report. Neurosurgery.
32:124–126. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Velander AJ, DeAngelis LM and Navi BB:
Intracranial hemorrhage in patients with cancer. Curr Atheroscler
Rep. 14:373–381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Navi BB, Reichman JS, Berlin D, Reiner AS,
Panageas KS, Segal AZ and DeAngelis LM: Intracerebral and
subarachnoid hemorrhage in patients with cancer. Neurology.
74:494–501. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lieu AS, Hwang SL, Howng SL and Chai CY:
Brain tumors with hemorrhage. J Formos Med Assoc. 98:365–367.
1999.PubMed/NCBI
|
|
45
|
Fukushima S, Terasaki M, Tajima Y and
Shigemori M: Granulocytic sarcoma: An unusual complication of acute
promyelocytic leukemia causing cerebellar hemorrhage. Case report J
Neurosurg. 105:912–915. 2006.
|
|
46
|
Reichman J, Singer S, Navi B, Reiner A,
Panageas K, Gutin PH and Deangelis LM: Subdural hematoma in
patients with cancer. Neurosurgery. 71:74–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
McIver JI, Scheithauer BW, Rydberg CH and
Atkinson JL: Metastatic hepatocellular carcinoma presenting as
epidural hematoma: Case report. Neurosurgery. 49:447–449.
2001.PubMed/NCBI
|
|
48
|
Würthner JU, Köhler G, Behringer D,
Lindemann A, Mertelsmann R and Lübbert M: Leukostasis followed by
hemorrhage complicating the initiation of chemotherapy in patients
with acute myeloid leukemia and hyperleukocytosis: A
clinicopathologic report of four cases. Cancer. 85:368–374. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shiber JR and Fines RE: Cerebral
hemorrhage due to hyperleukocytosis. J Emerg Med. 40:674–677. 2011.
View Article : Google Scholar
|
|
50
|
Nowacki P, Fryze C, Zdziarska B, Zyluk B,
Grzelec H and Dudzik T: Central nervous system leukostasis in
patients with leukemias and lymphomas. Folia Neuropathol. 33:59–65.
1995.PubMed/NCBI
|
|
51
|
Collins RC, Al-Mondhiry H, Chernik NL and
Posner JB: Neurologic manifestations of intravascular coagulation
in patients with cancer. A clinicopathologic analysis of 12 cases.
Neurology. 25:795–806. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schwarzbach CJ, Schaefer A, Ebert A, Held
V, Bolognese M, Kablau M, Hennerici MG and Fatar M: Stroke and
cancer: The importance of cancer-associated hypercoagulation as a
possible stroke etiology. Stroke. 43:3029–3034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lee AY: Cancer and thromboembolic disease:
Pathogenic mechanisms. Cancer Treat Rev. 28:137–140. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liebman HA: Thrombocytopenia in cancer
patients. Thromb Res. 133(Suppl 2): S63–S69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Thachil J, Falanga A, Levi M, Liebman H
and Di Nisio M: Scientific and Standardization Committee of the
International Society on Thrombosis and Hemostasis: Management of
cancer-associated disseminated intravascular coagulation: Guidance
from the SSC of the ISTH. J Thromb Haemost. 13:671–675. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Rogers LR: Cerebrovascular complications
in cancer patients. Neurol Clin. 21:167–192. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Nguyen T and DeAngelis LM: Stroke in
cancer patients. Curr Neurol Neurosci Rep. 6:187–192. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yagi T, Takahashi K, Tanikawa M, Seki M,
Abe T and Suzuki N: Fatal intracranial hemorrhage after intravenous
thrombolytic therapy for acute ischemic stroke associated with
cancer-related nonbacterial thrombotic endocarditis. J Stroke
Cerebrovasc Dis. 23:e413–e416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Rogers LR, Cho ES, Kempin S and Posner JB:
Cerebral infarction from non-bacterial thrombotic endocarditis.
Clinical and pathological study including the effects of
anticoagulation. Am J Med. 83:746–756. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Reisner SA, Brenner B, Haim N, Edoute Y
and Markiewicz W: Echocardiography in nonbacterial thrombotic
endocarditis: From autopsy to clinical entity. J Am Soc
Echocardiogr. 13:876–881. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu J and Frishman WH: Nonbacterial
Thrombotic Endocarditis: Pathogenesis, Diagnosis, and Management.
Cardiol Rev. 24:244–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Royter V and Cohen SN: Recurrent embolic
strokes and cardiac valvular disease in a patient with non-small
cell adenocarcinoma of lung. J Neurol Sci. 241:99–101. 2006.
View Article : Google Scholar
|
|
63
|
Lopez JA, Ross RS, Fishbein MC and Siegel
RJ: Nonbacterial thrombotic endocarditis: A review. Am Heart J.
113:773–784. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Steiner I: Nonbacterial thrombotic
endocarditis - a study of 171 case reports. Cesk Patol. 29:58–60.
1993.PubMed/NCBI
|
|
65
|
Edoute Y, Haim N, Rinkevich D, Brenner B
and Reisner SA: Cardiac valvular vegetations in cancer patients: A
prospective echocardiographic study of 200 patients. Am J Med.
102:252–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Correale JD, Monteverde DA, Bueri JA,
Reich EG and Lucatelli N: Craniocerebral involvement in lymphoma.
Arq Neuropsiquiatr. 48:306–314. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Noje C, Cohen K and Jordan LC: Hemorrhagic
and ischemic stroke in children with cancer. Pediatr Neurol.
49:237–242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zembower TR: Epidemiology of infections in
cancer patients. Cancer Treat Res. 161:43–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bos MM, Smeets LS, Dumay I and de Jonge E:
Bloodstream infections in patients with or without cancer in a
large community hospital. Infection. 41:949–958. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Fugate JE, Lyons JL, Thakur KT, Smith BR,
Hedley-Whyte ET and Mateen FJ: Infectious causes of stroke. Lancet
Infect Dis. 14:869–880. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Saynak M, Cosar-Alas R, Yurut-Caloglu V,
Caloglu M, Kocak Z and Uzal C: Chemotherapy and cerebrovascular
disease. J BUON. 13:31–36. 2008.PubMed/NCBI
|
|
72
|
Abt NB, Bydon M, De la Garza-Ramos R,
McGovern K, Olivi A, Huang J and Bydon A: Concurrent neoadjuvant
chemotherapy is an independent risk factor of stroke, all-cause
morbidity, and mortality in patients undergoing brain tumor
resection. J Clin Neurosci. 21:1895–1900. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wall JG, Weiss RB, Norton L, Perloff M,
Rice MA, Korzun AH and Wood WC: Arterial thrombosis associated with
adjuvant chemotherapy for breast carcinoma: A Cancer and Leukemia
Group B Study. Am J Med. 87:501–504. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Esteva FJ and Hortobagyi GN: Comparative
assessment of lipid effects of endocrine therapy for breast cancer:
Implications for cardiovascular disease prevention in
postmenopausal women. Breast. 15:301–312. 2006. View Article : Google Scholar
|
|
75
|
Robinson D, Garmo H, Lindahl B, Van
Hemelrijck M, Adolfsson J, Bratt O, Holmberg L and Stattin P:
Ischemic heart disease and stroke before and during endocrine
treatment for prostate cancer in PCBaSe Sweden. Int J Cancer.
130:478–487. 2012. View Article : Google Scholar
|
|
76
|
Mosca L, Grady D, Barrett-Connor E,
Collins P, Wenger N, Abramson BL, Paganini-Hill A, Geiger MJ,
Dowsett SA, Amewou-Atisso M, et al: Effect of raloxifene on stroke
and venous thromboembolism according to subgroups in postmenopausal
women at increased risk of coronary heart disease. Stroke.
40:147–155. 2009. View Article : Google Scholar
|
|
77
|
Murthy SB, Karanth S, Shah S, Shastri A,
Rao CP, Bershad EM and Suarez JI: Thrombolysis for acute ischemic
stroke in patients with cancer: A population study. Stroke.
44:3573–3576. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ligibel JA, James O'Malley A, Fisher M,
Daniel GW, Winer EP and Keating NL: Risk of myocardial infarction,
stroke, and fracture in a cohort of community-based breast cancer
patients. Breast Cancer Res Treat. 131:589–597. 2012. View Article : Google Scholar
|
|
79
|
Jagsi R, Griffith KA, Koelling T, Roberts
R and Pierce LJ: Stroke rates and risk factors in patients treated
with radiation therapy for early-stage breast cancer. J Clin Oncol.
24:2779–2785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Rosell J, Nordenskjöld B, Bengtsson NO,
Fornander T, Hatschek T, Lindman H, Malmström PO, Wallgren A, Stål
O, et al: Time dependent effects of adjuvant tamoxifen therapy on
cerebrovascular disease: Results from a randomised trial. Br J
Cancer. 104:899–902. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yang TL, Wu TC, Huang CC, Huang PH, Chung
CM, Lin SJ, Chen JW, Chan WL, Chiang CH and Leu HB: Association of
tamoxifen use and reduced cardiovascular events among asian females
with breast cancer. Circ J. 78:135–140. 2014. View Article : Google Scholar
|
|
82
|
Azoulay L, Yin H, Benayoun S, Renoux C,
Boivin JF and Suissa S: Androgen-deprivation therapy and the risk
of stroke in patients with prostate cancer. Eur Urol. 60:1244–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Jespersen CG, Nørgaard M and Borre M:
Androgen-deprivation therapy in treatment of prostate cancer and
risk of myocardial infarction and stroke: A nationwide Danish
population-based cohort study. Eur Urol. 65:704–709. 2014.
View Article : Google Scholar
|
|
84
|
Chung SD, Chen YK, Wu FJ and Lin HC:
Hormone therapy for prostate cancer and the risk of stroke: A
5-year follow-up study. BJU Int. 109:1001–1005. 2012. View Article : Google Scholar
|
|
85
|
Meng F, Zhu S, Zhao J, Vados L, Wang L,
Zhao Y, Zhao D and Niu Y: Stroke related to androgen deprivation
therapy for prostate cancer: A meta-analysis and systematic review.
BMC Cancer. 16:1802016. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Gerl A: Vascular toxicity associated with
chemotherapy for testicular cancer. Anticancer Drugs. 5:607–614.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Kuan AS, Teng CJ, Wu HH, Su VY, Chen YT,
Chien SH, Yeh CM, Hu LY, Chen TJ, Tzeng CH, et al: Risk of ischemic
stroke in patients with ovarian cancer: A nationwide
population-based study. BMC Med. 12:532014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Rollins N, Winick N, Bash R and Booth T:
Acute methotrexate neurotoxicity: Findings on diffusion-weighted
imaging and correlation with clinical outcome. AJNR Am J
Neuroradiol. 25:1688–1695. 2004.PubMed/NCBI
|
|
89
|
Jourdan E, Dombret H, Glaisner S, Micléa
JM, Castaigne S and Degos L: Unexpected high incidence of
intracranial subdural haematoma during intensive chemotherapy for
acute myeloid leukaemia with a monoblastic component. Br J
Haematol. 89:527–530. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lee CW, Muo CH, Liang JA, Sung FC and Kao
CH: Association of intensive morphine treatment and increased
stroke incidence in prostate cancer patients: A population-based
nested case– control study. Jpn J Clin Oncol. 43:776–781. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Stewart FA, Hoving S and Russell NS:
Vascular damage as an underlying mechanism of cardiac and cerebral
toxicity in irradiated cancer patients. Radiat Res. 174:865–869.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Tsai SJ, Huang YS, Tung CH, Lee CC, Lee
MS, Chiou WY, Lin HY, Hsu FC, Tsai CH, Su YC, et al: Increased risk
of ischemic stroke in cervical cancer patients: A nationwide
population-based study. Radiat Oncol. 8:412013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Santoro F, Tarantino N, Pellegrino PL,
Caivano M, Lopizzo A, Di Biase M and Brunetti ND: Cardiovascular
sequelae of radiation therapy. Clin Res Cardiol. 103:955–967. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Scott AS, Parr LA and Johnstone PA: Risk
of cerebrovascular events after neck and supraclavicular
radiotherapy: A systematic review. Radiother Oncol. 90:163–165.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Cheng SW, Wu LL, Ting AC, Lau H, Lam LK
and Wei WI: Irradiation-induced extracranial carotid stenosis in
patients with head and neck malignancies. Am J Surg. 178:323–328.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Elerding SC, Fernandez RN, Grotta JC,
Lindberg RD, Causay LC and McMurtrey MJ: Carotid artery disease
following external cervical irradiation. Ann Surg. 194:609–615.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Dorresteijn LD, Kappelle AC, Boogerd W,
Klokman WJ, Balm AJ, Keus RB, van Leeuwen FE and Bartelink H:
Increased risk of ischemic stroke after radiotherapy on the neck in
patients younger than 60 years. J Clin Oncol. 20:282–288. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Smith GL, Smith BD, Buchholz TA, Giordano
SH, Garden AS, Woodward WA, Krumholz HM, Weber RS, Ang KK and
Rosenthal DI: Cerebrovascular disease risk in older head and neck
cancer patients after radiotherapy. J Clin Oncol. 26:5119–5125.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Hung SK, Lee MS, Chiou WY, Lee CC, Chen
YC, Lai CL, Chien NC, Hsu WL, Liu DW, Su YC, et al: High incidence
of ischemic stroke occurrence in irradiated lung cancer patients: A
population-based surgical cohort study. PLoS One. 9:e943772014.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Woodward WA, Giordano SH, Duan Z,
Hortobagyi GN and Buchholz TA: Supraclavicular radiation for breast
cancer does not increase the 10-year risk of stroke. Cancer.
106:2556–2562. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Morris B, Partap S, Yeom K, Gibbs IC,
Fisher PG and King AA: Cerebrovascular disease in childhood cancer
survivors: A Children's Oncology Group Report. Neurology.
73:1906–1913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Mueller S, Sear K, Hills NK, Chettout N,
Afghani S, Gastelum E, Haas-Kogan D and Fullerton HJ: Risk of first
and recurrent stroke in childhood cancer survivors treated with
cranial and cervical radiation therapy. Int J Radiat Oncol Biol
Phys. 86:643–648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Mueller S, Fullerton HJ, Stratton K,
Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE,
Packer RJ, Sklar CA, et al: Radiation, atherosclerotic risk
factors, and stroke risk in survivors of pediatric cancer: A report
from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol
Phys. 86:649–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ruggiu M, Cuccuini W, Mokhtari K, Meignin
V, Peffault de Latour R, Robin M, Fontbrune FS, Xhaard A, Socié G,
et al: Case report: Central nervous system involvement of human
graft versus host disease: Report of 7 cases and a review of
literature. Medicine (Baltimore). 96:e83032017. View Article : Google Scholar
|
|
105
|
Najima Y, Ohashi K, Miyazawa M, Nakano M,
Kobayashi T, Yamashita T, Akiyama H and Sakamaki H: Intracranial
hemorrhage following allogeneic hematopoietic stem cell
transplantation. Am J Hematol. 84:298–301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Syed FI, Couriel DR, Frame D and
Srinivasan A: Central nervous system complications of hematopoietic
stem cell transplant. Hematol Oncol Clin North Am. 30:887–898.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Grauer O, Wolff D, Bertz H, Greinix H,
Kühl JS, Lawitschka A, Lee SJ, Pavletic SZ, Holler E and Kleiter I:
Neurological manifestations of chronic graft-versus-host disease
after allogeneic haematopoietic stem cell transplantation: Report
from the Consensus Conference on Clinical Practice in chronic
graft-versus-host disease. Brain. 133:2852–2865. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Saad AG, Alyea EP III, Wen PY, Degirolami
U and Kesari S: Graft-versus-host disease of the CNS after
allogeneic bone marrow transplantation. J Clin Oncol. 27:e147–e149.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Maffini E, Festuccia M, Brunello L,
Boccadoro M, Giaccone L and Bruno B: Neurologic Complications after
Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood
Marrow Transplant. 23:388–397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Goddeau RP and Alhazzani A: Headache in
stroke: A review. Headache. 53:1019–1022. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Yew KS and Cheng EM: Diagnosis of acute
stroke. Am Fam Physician. 91:528–536. 2015.PubMed/NCBI
|
|
112
|
Leiva-Salinas C and Wintermark M: Imaging
of acute ischemic stroke. Neuroimaging Clin N Am. 20:455–468. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liu YC, Lin TA, Ko PS, Wang HY, Chien SH,
Liu CJ, Chiou TJ, Hsiao LT, Gau JP and Liu JH: Cerebrovascular
disease after allogeneic hematopoietic stem cell transplantation:
Incidence, manifestations, risk and clinical outcome. Blood.
130:4527. 2017.
|
|
114
|
Zhang XH, Wang QM, Chen H, Chen YH, Han W,
Wang FR, Wang JZ, Zhang YY, Mo XD, Chen Y, et al: Clinical
characteristics and risk factors of Intracranial hemorrhage in
patients following allogeneic hematopoietic stem cell
transplantation. Ann Hematol. 95:1637–1643. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Bennett CL, Djulbegovic B, Norris LB and
Armitage JO: Colony-stimulating factors for febrile neutropenia
during cancer therapy. N Engl J Med. 368:1131–1139. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
McCune JS, Sullivan SD, Blough DK, Clarke
L, McDermott C, Malin J and Ramsey S: Colony-stimulating factor use
and impact on febrile neutropenia among patients with newly
diagnosed breast, colorectal, or non-small cell lung cancer who
were receiving chemotherapy. Pharmacotherapy. 32:7–19. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Rizzo JD, Brouwers M, Hurley P, Seidenfeld
J, Somerfield MR and Temin S: American society of clinical
oncology/american society of hematology clinical practice guideline
update on the use of epoetin and darbepoetin in adult patients with
cancer. J Oncol Pract. 6:317–320. 2010. View Article : Google Scholar :
|
|
118
|
Kreys ED, Kim TY, Delgado A and Koeller
JM: Impact of cancer supportive care pathways compliance on
emergency department visits and hospitalizations. J Oncol Pract.
10:168–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Poonawalla IB, Piller LB, Lairson DR, Chan
W and Du XL: Impact of hematopoietic growth factors on blood
transfusion needs, incidence of neutropenia, and overall survival
among elderly advanced ovarian cancer patients treated with
chemotherapy. Int J Gynecol Cancer. 26:95–103. 2016. View Article : Google Scholar
|
|
120
|
Du XL and Zhang Y: Risks of venous
thromboembolism, stroke, heart disease, and myelodysplastic
syndrome associated with hematopoietic growth factors in a large
population-based cohort of patients with colorectal cancer. Clin
Colorectal Cancer. 14:e21–e31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Du XL, Zhang Y and Hardy D: Associations
between hematopoietic growth factors and risks of venous
thromboembolism, stroke, ischemic heart disease and myelodysplastic
syndrome: Findings from a large population-based cohort of women
with breast cancer. Cancer Causes Control. 27:695–707. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Puhalla S, Bhattacharya S and Davidson NE:
Hematopoietic growth factors: Personalization of risks and
benefits. Mol Oncol. 6:237–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Calip GS, Malmgren JA, Lee WJ, Schwartz SM
and Kaplan HG: Myelodysplastic syndrome and acute myeloid leukemia
following adjuvant chemotherapy with and without granulocyte
colony-stimulating factors for breast cancer. Breast Cancer Res
Treat. 154:133–143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Rosenstock AS, Niu J, Giordano SH, Zhao H,
Wolff AC and Chavez-MacGregor M: Acute myeloid leukemia and
myelodysplastic syndrome after adjuvant chemotherapy: A
population-based study among older breast cancer patients. Cancer.
124:899–906. 2018. View Article : Google Scholar
|
|
125
|
Salamin O, Kuuranne T, Saugy M and
Leuenberger N: Erythropoietin as a performance-enhancing drug: Its
mechanistic basis, detection, and potential adverse effects. Mol
Cell Endocrinol. 464:75–87. 2018. View Article : Google Scholar
|
|
126
|
Bian J, Chen B, Hershman DL, Marks N,
Norris L, Schulz R and Bennett CL: Effects of the US food and drug
administration boxed warning of erythropoietin-stimulating agents
on utilization and adverse outcome. J Clin Oncol. 35:1945–1951.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Hollingsworth K, Romney MC, Crawford A and
McAna J: The impact of the risk evaluation mitigation strategy for
erythropoiesis-stimulating agents on their use and the incidence of
stroke in medicare subjects with chemotherapy-induced anemia with
lung and/or breast cancers. Popul Health Manag. 19:63–69. 2016.
View Article : Google Scholar
|
|
128
|
Palmer SC, Saglimbene V, Mavridis D,
Salanti G, Craig JC, Tonelli M, Wiebe N and Strippoli GF:
Erythropoiesis-stimulating agents for anaemia in adults with
chronic kidney disease: A network meta-analysis. Cochrane Database
Syst Rev. CD0105902014.PubMed/NCBI
|
|
129
|
Seliger SL, Zhang AD, Weir MR, Walker L,
Hsu VD, Parsa A, Diamantidis CJ and Fink JC:
Erythropoiesis-stimulating agents increase the risk of acute stroke
in patients with chronic kidney disease. Kidney Int. 80:288–294.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Szczech L: Chronic kidney disease:
Association between ESA use and stroke in patients with CKD. Nat
Rev Nephrol. 7:365–366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
England TJ, Sprigg N, Alasheev AM, Belkin
AA, Kumar A, Prasad K and Bath PM: Granulocyte-Colony Stimulating
Factor (G-CSF) for stroke: An individual patient data
meta-analysis. Sci Rep. 6:365672016. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Fan ZZ, Cai HB, Ge ZM, Wang LQ, Zhang XD,
Li L and Zhai XB: The efficacy and safety of granulocyte
colony-Stimulating factor for patients with stroke. J Stroke
Cerebrovasc Dis. 24:1701–1708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Huang X, Liu Y, Bai S, Peng L, Zhang B and
Lu H: Granulocyte colony stimulating factor therapy for stroke: A
pairwise meta-analysis of randomized controlled trial. PLoS One.
12:e01757742017. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Jacob L and Kostev K: Cancer is associated
with intraoperative and postprocedural complications and disorders.
J Cancer Res Clin Oncol. 142:777–781. 2016. View Article : Google Scholar
|
|
135
|
Kamiya-Matsuoka C, Cachia D, Yust-Katz S,
Rodriguez YA, Garciarena P, Rodarte EM and Tremont-Lukats IW:
Anderson Cancer Center Ischemic stroke in patients with gliomas at
The University of Texas-M.D. J Neurooncol. 125:143–148. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Chen CW, Cheng TJ, Ho CH, Wang JJ, Weng
SF, Hou YC, Cheng HC, Chio CC, Shan YS and Chang WT: Increased risk
of brain cancer incidence in stroke patients: A clinical case
series, population-based and longitudinal follow-up study.
Oncotarget. 8:108989–108999. 2017. View Article : Google Scholar
|
|
137
|
Sealy-Jefferson S, Cote ML, Chlebowski RT,
Rexrode KM and Simon MS: Post-stroke cancer risk among
postmenopausal women: The Women's Health Initiative. Womens Health
Issues. 28:29–34. 2018. View Article : Google Scholar
|
|
138
|
Del Ben M, Caporale A, Feole K, Alessandri
C and Angelico F: Intracranial hemorrage due to brain metastases in
an Italian HCV patient with hepatocellular carcinoma. J Exp Clin
Cancer Res. 22:641–644. 2003.
|
|
139
|
Ponzoni M, Ferreri AJ, Campo E, Facchetti
F, Mazzucchelli L, Yoshino T, Murase T, Pileri SA, Doglioni C,
Zucca E, et al: Definition, diagnosis, and management of
intravascular large B-cell lymphoma: Proposals and perspectives
from an international consensus meeting. J Clin Oncol.
25:3168–3173. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Bal S, Menon B and Demchuk A: Relationship
of endocarditis, disseminated intravascular coagulation, and
embolic signals in cancer with stroke. Ann Neurol. 71:1462012.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Reagan TJ and Okazaki H: The thrombotic
syndrome associated with carcinoma. A clinical and neuropathologic
study. Arch Neurol. 31:390–395. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
el-Shami K, Griffiths E and Streiff M:
Nonbacterial thrombotic endocarditis in cancer patients:
Pathogenesis, diagnosis, and treatment. Oncologist. 12:518–523.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Singhal AB, Topcuoglu MA and Buonanno FS:
Acute ischemic stroke patterns in infective and nonbacterial
thrombotic endocarditis: A diffusion-weighted magnetic resonance
imaging study. Stroke. 33:1267–1273. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Angarone M: Fungal infections in cancer
patients. Cancer Treat Res. 161:129–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Schellongowski P and Staudinger T:
Leukostasis and tumor lysis: Important complications of
hyperleukocytosis. Internist (Berl). 54:1051–1060. 2013.In German.
View Article : Google Scholar
|
|
146
|
Xie X, Chen L, Zeng J, Qin C, Cheng D, Wei
X and Liang Z: Clinical features and biological markers of lung
cancer-associated stroke. J Int Med Res. 44:1483–1491. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kono T, Ohtsuki T, Hosomi N, Takeda I,
Aoki S, Sueda Y, Ishihara K, Nakamura T, Yamawaki T and Matsumoto
M: Cancer-associated ischemic stroke is associated with elevated
D-dimer and fibrin degradation product levels in acute ischemic
stroke with advanced cancer. Geriatr Gerontol Int. 12:468–474.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Guo YJ, Chang MH, Chen PL, Lee YS, Chang
YC and Liao YC: Predictive value of plasma (D)-dimer levels for
cancer-related stroke: A 3-year retrospective study. J Stroke
Cerebrovasc Dis. 23:e249–e254. 2014. View Article : Google Scholar
|
|
149
|
Selvik HA, Bjerkreim AT, Thomassen L,
Waje-Andreassen U, Naess H and Kvistad CE: When to Screen Ischaemic
Stroke Patients for Cancer. Cerebrovasc Dis. 45:42–47. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Kim SJ, Park JH, Lee MJ, Park YG, Ahn MJ
and Bang OY: Clues to occult cancer in patients with ischemic
stroke. PLoS One. 7:e449592012. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Cappellari M, Carletti M, Micheletti N,
Tomelleri G, Ajena D, Moretto G and Bovi P: Intravenous alteplase
for acute ischemic stroke in patients with current malignant
neoplasm. J Neurol Sci. 325:100–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Graber JJ, Nayak L and Deangelis LM: Use
of recombinant tissue plasminogen activator in cancer patients with
acute stroke. J Neurooncol. 107:571–573. 2012. View Article : Google Scholar
|
|
153
|
Sobolewski P, Brola W, Szczuchniak W,
Fudala M and Sobota A: Safety of intravenous thrombolysis for acute
ischaemic stroke including concomitant neoplastic disease sufferers
- experience from Poland. Int J Clin Pract. 69:666–673. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Murthy SB, Moradiya Y, Shah S, Shastri A,
Bershad EM and Suarez JI: In-hospital outcomes of thrombolysis for
acute ischemic stroke in patients with primary brain tumors. J Clin
Neurosci. 22:474–478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Fink JN and McAuley DL: Safety of
anticoagulation for cerebral venous thrombosis associated with
intracerebral hematoma. Neurology. 57:1138–1139. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Soleau SW, Schmidt R, Stevens S, Osborn A
and MacDonald JD: Extensive experience with dural sinus thrombosis.
Neurosurgery. 52:534–544. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
van der Hulle T, den Exter PL, Kooiman J,
van der Hoeven JJ, Huisman MV and Klok FA: Meta-analysis of the
efficacy and safety of new oral anticoagulants in patients with
cancer-associated acute venous thromboembolism. J Thromb Haemost.
12:1116–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Raskob GE, van Es N, Verhamme P, Carrier
M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri
MF, et al: Hokusai VTE Cancer Investigators: Edoxaban for the
Treatment of Cancer-Associated Venous Thromboembolism. N Engl J
Med. 378:615–624. 2018. View Article : Google Scholar
|
|
159
|
Matsumoto K, Ohta M and Takeshita I:
Reversible non-thrombotic occlusion of the superior sagittal sinus
caused by metastatic malignant lymphoma - case report. Neurol Med
Chir (Tokyo). 43:349–351. 2003. View Article : Google Scholar
|
|
160
|
Short NJ and Connors JM: New oral
anticoagulants and the cancer patient. Oncologist. 19:82–93. 2014.
View Article : Google Scholar :
|
|
161
|
van Es N and Büller HR: Using direct oral
anticoagulants (DOACs) in cancer and other high-risk populations.
Hematology Am Soc Hematol Educ Program. 2015:125–131. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Magne JL, Pirvu A, Sessa C, Cochet E,
Blaise H and Ducos C: Carotid artery revascularisation following
neck irradiation: Immediate and long-term results. Eur J Vasc
Endovasc Surg. 43:4–7. 2012. View Article : Google Scholar
|
|
163
|
Rominger A, Saam T, Wolpers S, Cyran CC,
Schmidt M, Foerster S, Nikolaou K, Reiser MF, Bartenstein P and
Hacker M: 18F-FDG PET/CT identifies patients at risk for
future vascular events in an otherwise asymptomatic cohort with
neoplastic disease. J Nucl Med. 50:1611–1620. 2009. View Article : Google Scholar : PubMed/NCBI
|
